Cigna Investments’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $338K | Sell |
3,861
-56
| -1% | -$4.9K | 0.06% | 315 |
|
2025
Q1 | $268K | Sell |
3,917
-57
| -1% | -$3.9K | 0.05% | 358 |
|
2024
Q4 | $309K | Hold |
3,974
| – | – | 0.05% | 340 |
|
2024
Q3 | $266K | Sell |
3,974
-88
| -2% | -$5.89K | 0.05% | 375 |
|
2024
Q2 | $460K | Sell |
4,062
-40
| -1% | -$4.53K | 0.09% | 221 |
|
2024
Q1 | $569K | Sell |
4,102
-41
| -1% | -$5.69K | 0.11% | 192 |
|
2023
Q4 | $514K | Sell |
4,143
-39
| -0.9% | -$4.84K | 0.11% | 192 |
|
2023
Q3 | $390K | Sell |
4,182
-535
| -11% | -$49.9K | 0.09% | 238 |
|
2023
Q2 | $606K | Hold |
4,717
| – | – | 0.11% | 171 |
|
2023
Q1 | $548K | Sell |
4,717
-137
| -3% | -$15.9K | 0.11% | 193 |
|
2022
Q4 | $550K | Sell |
4,854
-31
| -0.6% | -$3.51K | 0.11% | 187 |
|
2022
Q3 | $393K | Sell |
4,885
-111
| -2% | -$8.93K | 0.09% | 247 |
|
2022
Q2 | $372K | Sell |
4,996
-1,840
| -27% | -$137K | 0.07% | 274 |
|
2022
Q1 | $875K | Sell |
6,836
-1,968
| -22% | -$252K | 0.11% | 180 |
|
2021
Q4 | $1.18M | Sell |
8,804
-3,320
| -27% | -$446K | 0.09% | 170 |
|
2021
Q3 | $1.66M | Buy |
12,124
+120
| +1% | +$16.4K | 0.12% | 147 |
|
2021
Q2 | $1.28M | Sell |
12,004
-2,024
| -14% | -$216K | 0.09% | 190 |
|
2021
Q1 | $1.26M | Buy |
14,028
+536
| +4% | +$48.1K | 0.09% | 212 |
|
2020
Q4 | $1.25M | Buy |
13,492
+1,128
| +9% | +$104K | 0.1% | 180 |
|
2020
Q3 | $1.27M | Sell |
12,364
-512
| -4% | -$52.8K | 0.12% | 153 |
|
2020
Q2 | $1.31M | Buy |
12,876
+7,908
| +159% | +$801K | 0.12% | 157 |
|
2020
Q1 | $335K | Buy |
4,968
+1,228
| +33% | +$82.8K | 0.04% | 423 |
|
2019
Q4 | $225K | Buy |
+3,740
| New | +$225K | 0.02% | 596 |
|